A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
4-Hydroxytestosterone
Tetrodotoxin
The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Lemborexant.
4-Hydroxytestosterone
APD791
The risk or severity of adverse effects can be increased when APD791 is combined with Lemborexant.
4-Hydroxytestosterone
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Lemborexant.
4-Hydroxytestosterone
Renzapride
The risk or severity of adverse effects can be increased when Renzapride is combined with Lemborexant.
4-Hydroxytestosterone
Pagoclone
The risk or severity of adverse effects can be increased when Pagoclone is combined with Lemborexant.
4-Hydroxytestosterone
Bifeprunox
The risk or severity of adverse effects can be increased when Bifeprunox is combined with Lemborexant.
4-Hydroxytestosterone
Cilansetron
The risk or severity of adverse effects can be increased when Cilansetron is combined with Lemborexant.
4-Hydroxytestosterone
Osanetant
The risk or severity of adverse effects can be increased when Osanetant is combined with Lemborexant.
4-Hydroxytestosterone
Fluspirilene
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Lemborexant.
4-Hydroxytestosterone
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Lemborexant.
4-Hydroxytestosterone
Amineptine
The risk or severity of adverse effects can be increased when Amineptine is combined with Lemborexant.
4-Hydroxytestosterone
Methaqualone
The risk or severity of adverse effects can be increased when Methaqualone is combined with Lemborexant.
4-Hydroxytestosterone
Lysergic acid diethylamide
The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Lemborexant.
4-Hydroxytestosterone
Urethane
The risk or severity of adverse effects can be increased when Urethane is combined with Lemborexant.
4-Hydroxytestosterone
Nomifensine
The risk or severity of adverse effects can be increased when Nomifensine is combined with Lemborexant.
4-Hydroxytestosterone
Nialamide
The risk or severity of adverse effects can be increased when Nialamide is combined with Lemborexant.
4-Hydroxytestosterone
Methapyrilene
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Lemborexant.
4-Hydroxytestosterone
Iproniazid
The risk or severity of adverse effects can be increased when Iproniazid is combined with Lemborexant.
4-Hydroxytestosterone
Aniracetam
The risk or severity of adverse effects can be increased when Aniracetam is combined with Lemborexant.
4-Hydroxytestosterone
Phenethylamine
The risk or severity of adverse effects can be increased when Phenethylamine is combined with Lemborexant.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3